Killing Off 30-second Spot Is Bad Medicine for OTC Drug Industry

NEW YORK (AdAge.com) — We've all heard it: The 30-second spot is dying, with penny-pinching procurement practices driving the final nail in its coffin. But some interesting new data on the over-the-counter drug category — the biggest adopter of the 15-second spot over the longer version — might just argue for its revival.

No Responses to “Killing Off 30-second Spot Is Bad Medicine for OTC Drug Industry”

Post a Comment